Juno Therapeutics Inc. (JUNO)

86.96
0.09 0.10
Prev Close 86.87
Open 86.97
Day Low/High 86.90 / 87.01
52 Wk Low/High 19.62 / 87.01
Volume 3.70M
Avg Volume 4.51M
Exchange
Shares Outstanding 116.11M
Market Cap 10.10B
EPS -4.10
Div & Yield N.A. (N.A)

Start Reflecting

2015 is going to play out differently than 2014.

Juno Therapeutics Announces Closing Of Initial Public Offering, Including Full Exercise Of Underwriters' Option To Purchase Additional Shares

Juno Therapeutics Announces Closing Of Initial Public Offering, Including Full Exercise Of Underwriters' Option To Purchase Additional Shares

Juno Therapeutics, Inc. (NASDAQ:JUNO) today announced the closing of its initial public offering of 12.

Oil Lang Syne

The market's oil worries are long forgotton.

Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market

Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market

The power to control drug prices in the U.S. now has shifted firmly to cost-cutting insurance carriers and pharmacy benefit managers and away from biotech and drug companies.

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Cramer will be watching for existing home sales data, Walgreen's earnings and Santa's sleigh.

Juno Therapeutics Debuts on the Nasdaq, Stock Soars 50%

Juno Therapeutics Debuts on the Nasdaq, Stock Soars 50%

Juno Therapeutics CEO Hans Bishop tells TheStreet's Jill Malandrino that the company is focused on improving cancer patients' treatment.

Sector Spotlight: For Internet Service Providers the Issue Is Free ISPs

Sector Spotlight: For Internet Service Providers the Issue Is Free ISPs

Still, the ad-driven Net business model has yet to prove a winner.